Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease

被引：0
|
作者：
Barone, P.
Poewe, W.
Tolosa, E.
Rascol, O.
Massey, D.
Debieuvre, C.
Albrecht, S.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
    Wermuth, L
    EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
  • [2] Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Barone, Paolo
    Poewe, Werner
    Albrecht, Stefan
    Debieuvre, Catherine
    Massey, Dan
    Rascol, Olivier
    Tolosa, Eduardo
    Weintraub, Daniel
    LANCET NEUROLOGY, 2010, 9 (06): : 573 - 580
  • [3] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
  • [4] Pramipexole Ameliorates Depression in Parkinson's Disease: A Randomized Double-Blind Versus Placebo Trial
    Barone, Paolo
    Poewe, Werner
    Massey, Dan
    Debieuvre, Catherine Debove
    NEUROLOGY, 2009, 72 (11) : A413 - A413
  • [5] Atomoxetine for the treatment of depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Weintraub, D.
    Mavandadi, S.
    Horn, S.
    Hurtig, H.
    Siderowf, A.
    Duda, J.
    Stern, M.
    MOVEMENT DISORDERS, 2009, 24 : S286 - S286
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [7] Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study
    Devos, D.
    Poirot, I.
    Dujardin, K.
    Duhem, S.
    Lucas, B.
    Waucquier, N.
    Moreau, C.
    Bocquillon, P.
    Devos, P.
    Ajebbar, K.
    Thielemans, B.
    Cottencin, O.
    Thomas, P.
    Destee, A.
    Bordet, R.
    Defebvre, L.
    MOVEMENT DISORDERS, 2007, 22 : S223 - S224
  • [8] Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study
    Lieberman, A
    Ranhosky, A
    Korts, D
    NEUROLOGY, 1997, 49 (01) : 162 - 168
  • [9] Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
    Devos, David
    Dujardin, Kathy
    Poirot, Isabelle
    Moreau, Caroline
    Cottencin, Olivier
    Thomas, Pierre
    Destee, Alain
    Regis, Bordet
    Defebvre, Luc
    MOVEMENT DISORDERS, 2008, 23 (06) : 850 - 857
  • [10] Double-blind, placebo-controlled trials for surgical interventions in Parkinson disease
    Olanow, CW
    ARCHIVES OF NEUROLOGY, 2005, 62 (09) : 1343 - 1344
12345